8-KEarnings & ResultsExhibits & Filings

Guardant Health, Inc. 8-K Report, Financial Results (May 6, 2021)

Filed May 6, 2021For Securities:GH

Summary

Guardant Health, Inc. filed an 8-K on May 6, 2021, to announce its financial results for the fiscal quarter ended March 31, 2021. The primary focus of this filing is the accompanying press release, which details the company's performance and outlook. Investors should pay close attention to the financial metrics and any forward-looking statements contained within the press release, as this is where the core operational and financial insights are presented. While the 8-K itself is a procedural filing, the press release it incorporates provides the substance. Key information likely includes revenue figures, earnings per share, and potentially updates on product development, clinical trial progress, and commercialization efforts for their liquid biopsy tests. The company's performance in the first quarter of 2021 is critical for understanding its trajectory and ability to achieve its longer-term strategic objectives in the rapidly evolving oncology diagnostics market.

Key Highlights

  • 1Guardant Health announced its financial results for the first fiscal quarter ended March 31, 2021, via an 8-K filing on May 6, 2021.
  • 2The 8-K filing primarily incorporates a press release (Exhibit 99.1) containing the detailed financial results and operational updates.
  • 3Investors are directed to the press release for comprehensive information on the company's performance during the reported quarter.
  • 4The filing serves as an official notification of the company's quarterly financial performance.
  • 5Information furnished in this report, including Exhibit 99.1, is not deemed 'filed' for certain regulatory purposes, which is standard for earnings release attachments.
  • 6Exhibit 104 provides the Cover Page Interactive Data File in Inline XBRL format, facilitating easier data extraction for analysis.

Frequently Asked Questions

The detailed financial results are presented in the press release filed as Exhibit 99.1 to the 8-K filing dated May 6, 2021. This press release is incorporated by reference into the 8-K.

The 8-K itself does not contain the detailed financial metrics. These are found within the press release (Exhibit 99.1). Investors should review the press release for information such as revenue, earnings per share, and any specific segment performance.

Forward-looking statements and guidance are typically included in the press release accompanying earnings announcements. Investors should carefully read Exhibit 99.1 for any commentary on future expectations or business outlook.

No, the information furnished in this Current Report on Form 8-K, including Exhibit 99.1, is generally furnished and not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, unless expressly incorporated by reference into another filing.